Lomustine (INN), also called 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU
) is an alkylating nitrosourea compound used in chemotherapy. It is closely ...
Drug type: Lomustine is an anti-cancer ("antineoplastic" or "cytotoxic")
chemotherapy drug. This medication is classified as an "alkylating agent." (For
more detail ...
Lomustine (CCNU) is usually taken as a single dose only once every 6 weeks.
Do NOT take a dose of lomustine (CCNU) more than once within a 6-week period
Learn about the prescription medication CeeNU (Lomustine Capsules), drug
uses, dosage, side effects, drug interactions, warnings, reviews and patient ...
Jan 6, 2016 ... Lomustine is an alkylating agent used in the treatment of brain tumors and
Dec 1, 2015 ... Lomustine is used alone or in combination with other medicines to treat brain
tumors, Hodgkin's disease, and other kinds of cancer.
Find patient medical information for lomustine oral on WebMD including its uses,
side effects and safety, interactions, pictures, warnings and user ratings.
Consumer information about the medication LOMUSTINE - ORAL (Ceenu),
includes side effects, drug interactions, recommended dosages, and storage ...
Feb 27, 2012 ... This page contains brief information about lomustine and a collection of links to
more information about the use of this drug, research results, ...
Medscape - Brain cancer and non-Hodgkin lymphoma dosing for Gleostine,
CCNU (lomustine), frequency-based adverse effects, comprehensive interactions